Small-cell lung cancer (SCLC) has limited second-line treatment options after chemotherapy. We assessed the efficacy and safety of lurbinectedin combined with pembrolizumab in relapsed SCLC patients who had not received prior immunotherapy, aiming to prevent early progression and achieve sustained responses.
Regina Barragan-Carrillo , Miguel Zugman , Daniela Castro , Xiaochen Li , Koral Shah , Lily Lau , Ruchi Agarwal , Aaron Lee , Skylar…
Rep. Buddy Carter (R-Ga.) introduced a new bill this week aiming to rename Greenland to “Red, White, and Blueland,” as President Trump seeks to acquire…
Laurence Albiges Gustave Roussy, Paris-Saclay University Laurence Albiges , Cristina Suárez , Thomas Powles , Robert Motzer , Walter Stadler , Wilson Miller Jr., Carlos…
Key PointsDisease type, baseline cytopenia, lymphodepletion intensity, and systemic inflammation were strongly associated with severe eICAHT.We validated 2
Wenxin Xu Dana-Farber Cancer Institute, Harvard Medical School Wenxin Xu , Sai Vikram Vemula , Robert Motzer , Aparna Chhibber , Deepthi Chowbene , Nahuel…
New Drugs in Low-Risk MDS: Where do we Stand? – IACH / cancer, IACH, MDS, OncoDaily, Oncology, Talha Badar
ORDER granting 66 Emergency MOTION to Enforce 50 Order on Motion for TRO. So Ordered by Chief Judge John J. McConnell, Jr. on 2/10/2025. (Jackson,…
Bixia Tang , Xinan Sheng , Jun Guo , Haitao Niu , Yali Shen , Shusuan Jiang , Bin Fu , Jianming Guo , Wasilijiang…
The federal order temporarily halts the Trump administration’s plans to slash $4 billion in overhead costs for research at universities and medical centers into diseases…
